Matt Smith joined BioMed Realty last year as the Director for Leasing and is accountable for the

company’s approximate 1m sft UK portfolio.

In his previous role, he was responsible for the running of a multi-asset multi-sector UK commercial

real estate portfolio, valued at £1bn, on behalf of institutional investors. Matt also oversaw the

creation of the London office of a pan-European Real Estate asset management company as

Managing Director.

He has over 15 years’ experience in leasing, acquisition, valuation and asset management functions.

Matt received his Batchelor of Engineering Degree at the University of Leeds, his Post Graduate

Diploma from London South Bank University, and is also a Chartered Surveyor.

Emily Slupek is a Partner at Bidwells, with a focus on project management of R&D real estate across the

Golden Triangle of Oxford, Cambridge, and London.

She excels in delivering complex projects, with expertise in repurposing commercial spaces, labs,

offices, and mixed-use developments. Currently, she works on projects at the Harwell Campus and with

the University of Oxford.

Emily is a recognized figure in the innovation sector, regularly exploring future market trends with

speaking slots at conferences and roundtables.

Mr. Matthew Powers is the CEO of Nan Fung Life Sciences Real Estate where he leads the company strategy to providently address the unmet needs of the Life Science Industry by delivering best-in-class real estate solutions to vital innovation clusters. Prior to launching NFLSRE, Mr. Powers has over 25 years of experience working for large biotechnology and pharmaceutical companies in strategy, supply, operations and real estate positions. Mr. Powers made a very successful transition as a leader of life science brokerage at JLL in 2015, where he leveraged his prior experiences to be a strategic advisor to organizations across the full spectrum of the life science industry as well as geographical markets.

Earlier in his career, Mr. Powers held a hybrid role as Head of Real Estate and Infrastructure Operations as well as Strategy Program Manager for Merck Millipore’s Biosciences Division. He led the company’s real estate strategy and transaction management, responsible for a portfolio of six million square feet across 41 locations. In 2006, Mr. Powers established Chimera Management, a real estate solutions service provider to biotech and life sciences organizations. Earlier in his career, Mr. Powers enjoyed the fortuity of working for venerated biotech pillars Genzyme and Genetics Institute, the latter being acquired by the pharmaceutical giant Wyeth during his tenure.

Anna Strongman is CEO of Oxford University Development (OUD), a joint

venture between Oxford University and Legal & General set up to build

Innovation Districts and subsidised accommodation for graduate students

and the university workforce.

Anna was previously Managing Partner of Argent LLP in London, where

she spent 12 years executing a range of asset, development, and business

planning projects. Highlights included leading the Asset Management of

King’s Cross, developing Coal Drops Yard, and setting up a BTR portfolio

with JV partners Related. Anna was instrumental in building the business

from 40 people to a team of 200 over a ten-year period and led the

corporate side of the business as Managing Partner.

Before joining Argent, Anna worked in the planning and economic development team of Arup, worked for DTZ

in Scotland, and lived for 18 months in Japan, where she studied Japanese and conducted research at the Japan

Productivity Centre as a Daiwa Scholar.